AH — Aleafia Health Cashflow Statement
0.000.00%
HealthcareSpeculativeMicro CapNeutral
- CA$12.09m
- CA$53.70m
- CA$43.12m
- 14
- 50
- 25
- 18
Annual cashflow statement for Aleafia Health, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2017 October 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2022 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 15 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -5.94 | -18.5 | -39.6 | -247 | -170 |
Depreciation | |||||
Amortisation | |||||
Deferred Taxes | |||||
Non-Cash Items | 3.49 | 11.8 | 13.7 | 231 | 129 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.146 | -4.18 | -13.8 | 0.658 | -4.76 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Cash from Operating Activities | -2.55 | -10.3 | -30.9 | -7.63 | -36.2 |
Capital Expenditures | -0.044 | -12.1 | -16.1 | -17.8 | -4.66 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | 2.92 | 27.1 | 1.57 | 0 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.044 | -9.23 | 11 | -16.2 | -4.66 |
Financing Cash Flow Items | 0.023 | — | -2.95 | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 8.34 | 44.9 | 34.7 | 13.1 | 11.9 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 5.74 | 25.3 | 14.8 | -10.7 | -29 |